Geographic equity in cancer care is often framed as an access problem, but this large registry analysis reframes it as a quality-of-care problem — one where where you live measurably shapes whether you receive treatments that clinical guidelines consider optimal, independent of tumor biology or demographics.
Drawing on SEER data spanning 2010 to 2022, investigators analyzed over 516,000 patients with early-stage kidney, prostate, or testicular cancer, stratifying counties by USDA Rural-Urban Continuum Codes into urban, rural-adjacent, and rural-remote categories. For cT1a kidney cancer, the key quality marker was receipt of partial nephrectomy — the nephron-sparing standard — versus radical nephrectomy or no surgery. For prostate cancer, concordance required active surveillance in low-risk, AS-eligible disease and definitive local therapy in higher-risk cases. Rural residence was independently associated, across all three malignancies, with reduced odds of receiving NCCN-aligned initial management after adjustment for demographics, clinical stage, and time period. The magnitude of the rural-remote disadvantage was consistent and not explained by case-mix alone.
This finding sits within a well-established literature on rural cancer disparities, but the study's strength lies in its specificity: it isolates guideline concordance as the outcome, rather than survival or mortality, which can be confounded by late-stage presentation. By focusing on early-stage disease — where guideline recommendations are clearest — the analysis isolates a care-delivery gap rather than a detection gap. The key limitation is that SEER lacks data on individual hospital volume, surgeon specialty, and patient preference, all of which influence treatment selection. Active surveillance uptake, in particular, is known to be influenced by shared decision-making quality. Still, with over half a million patients and a 12-year window, this is among the most comprehensive assessments of rural urologic oncology equity to date. It signals that guideline implementation infrastructure, not just facility access, needs targeted intervention in non-metropolitan settings.